HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The induction of immunoblastic T cell sarcomas by virus-transformed prothymocytes.

Abstract
The ontogeny of thymus-dependent lymphoid tumors induced by murine sarcoma-murine leukemia virus (MSV-MuLV) was investigated. Tumors that developed in spleens of infected mice 6 or more months after the injection of virus were diagnosed as immunoblastic T cell sarcomas. Cells derived from the tumors and established as a continuous cell line expressed the thymus leukemia (TL), brain-associated theta (BAT), and Qa2 cell surface antigens but lacked either the Ly 1 or Ly 2, 3 mature T cell differentiation antigens. In addition, the tumor cell expressed c type viral antigens, and had receptors for the lectin peanut agglutinin. The tumor cells were inert when tested for their capacity to respond in several functional T cell assays. Taken together, these data support the hypothesis that the primary target of malignant transformation by MSV-MuLV is a prothymocyte.
AuthorsC L Reinisch, S E Kurtz, E A Morris, A Lampert
JournalThe American journal of pathology (Am J Pathol) Vol. 101 Issue 2 Pg. 265-82 (Nov 1980) ISSN: 0002-9440 [Print] United States
PMID6254363 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antigens, Surface
  • Antigens, Viral
  • Lectins
  • Receptors, Immunologic
Topics
  • Animals
  • Antigens, Surface (immunology)
  • Antigens, Viral (immunology)
  • Cell Transformation, Viral
  • Female
  • Lectins (immunology)
  • Leukemia Virus, Murine (immunology)
  • Lymphoma (immunology, physiopathology)
  • Mice
  • Receptors, Immunologic (analysis)
  • Sarcoma Viruses, Murine (immunology)
  • Sarcoma, Experimental (immunology, physiopathology)
  • Splenic Neoplasms (immunology, physiopathology)
  • T-Lymphocytes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: